Incannex Healthcare Inc. (IXHL)

NASDAQ: IXHL · Real-Time Price · USD

0.4000

-0.0218 (-5.17%)

At close: Aug 13, 2025, 4:00 PM

0.3900

-0.0100 (-2.50%)

Pre-market: Aug 14, 2025, 9:25 AM EDT

Incannex Healthcare Employees

Incannex Healthcare had 9 employees as of June 30, 2024. The number of employees increased by 6 or 200.00% compared to the previous year.

Employees

9

Change

6

Growth

200.00%

Revenue / Employee

$10,889

Profits / Employee

-$2,415,889

Market Cap

37.48M

Employees Chart

Employees History

Date	Employees	Change	Growth
Jun 30, 2024	9	6	200.00%
Jun 30, 2021	3	1	50.00%
Jun 30, 2020	2	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

IXHL News

6 days ago - Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea - GlobeNewsWire
14 days ago - Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term - GlobeNewsWire
14 days ago - Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial - Benzinga
15 days ago - Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X - GlobeNewsWire
20 days ago - Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo - GlobeNewsWire
7 weeks ago - Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch - GlobeNewsWire
2 months ago - Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X - GlobeNewsWire
2 months ago - Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - GlobeNewsWire